Associate Director, Statistical Programming
Job Description
Key Skills Required
Master these to land this role
Want to know if you're a match for this job?
Definium Therapeutics is a late-stage clinical biopharmaceutical company focused on advancing psychiatric treatments using psychedelics. Their lead product candidate, lysergide tartrate (a proprietary orally disintegrating tablet form of LSD), targets generalized anxiety, major depressive disorder, and posttraumatic stress disorder. Their pipeline also includes DT402, the R-enantiomer of MDMA, under development for autism spectrum disorder (ASD), specifically addressing social communication challenges.
As Associate Director, Statistical Programming, this role provides statistical programming support for compounds at various stages of development, including clinical trials, regulatory filings, and commercialization. Reporting to the Director, Statistical Programming Lead, the role involves:
Responsibilities:
- Serve as the study lead programmer for assigned clinical trial(s), collaborating with study statisticians, data management, and other team members to provide statistical programming support.
- Review and ensure the quality of Define packages, including aCRF, SDTM/ADaM datasets, Pinnacle 21 reports, cSDRG/ADRG, and define XML for assigned clinical trials.
- Ensure compliance with CDISC standards and regulatory requirements for integrated datasets during electronic submissions.
- Work closely with the study lead biostatistician to manage vendor deliverables, ensuring quality and adherence to timelines.
- Perform independent validation (QC) to verify the accuracy of statistical vendor deliverables, datasets, and analytic outputs.
- Validate analytic outputs produced by internal biostatisticians or statistical programmers.
- Collaborate with the Clinical Data Management group to produce systematic data reports for efficient clinical trial data review and cleaning.
- Review CRF and/or Data Transfer Specifications to ensure data collection meets study objectives, requirements, and CDISC standards.
- Provide input to Statistical Analysis Plans and TLF Shells for Tables/Listings/Figures.
- Conduct statistical analyses to support publications and regulatory correspondence as needed.
- Perform other duties as assigned.
Qualifications and Skills:
- A Master’s Degree in Biostatistics, Statistics, Computer Science, or a related field with at least 12 years of experience in statistical programming support within clinical trials.
- Deep understanding of data standards and experience in Pinnacle 21 validation reports and creating Define XML packages for regulatory filings.
- Proficient in statistical computational software such as SAS, including complex data steps, SAS macro languages, and commonly used analysis procedures (e.g., PROC Freq, PROC REPORT, PROC GLM, PROC MIXED).
- Demonstrated ability to collaborate with biostatisticians, Clinical Data Management, and colleagues across functions to achieve common goals.
- Strong organizational and project management skills, with a demonstrated interest in continuous learning and growth.
- Proven ability to work effectively on multiple projects in a fast-paced environment.
- Detail-oriented with high standards for excellence in statistical programming deliverables.
- Effective communication and teamwork skills, particularly in a work-from-home environment.
Preferred Experience:
- Experience in data structure and data analysis in CNS (Central Nervous System) clinical trials.
- Experience in providing integrated data analysis support for regulatory filings.
How would you rate this job post?
See what other professionals think about this role.
Similar Opportunities
More Openings at Definium Therapeutics
Explore Top Companies in this Space
Foresight Diagnostics
Biotechnology / Precision Medicine / Health Tech
ICON plc
Biotechnology Research / Clinical Research / Pharmaceutical Services / Medical Device Development
Seed
Biotechnology / Pharmaceuticals / Health & Wellness / Consumer Packaged Goods
Xenon Pharmaceuticals
Biotechnology & Pharmaceutical R&D / Neuroscience & Ion Channel Science / Clinical-Stage Drug Development / Genomic-Driven Therapeutics
Definium Therapeutics
View Company ProfileDefinium Therapeutics (operating at definiumtx.com) is a clinical biopharmaceutical company engineered for developing novel product candidates to treat brain health disorders. Founded in 2019 by Jamon "JR" Rahn, Stephen Hurst, and Scott Freeman and headquartered in New York, Definium Therapeutics is forging a new era in psychiatry by harnessing the full therapeutic potential of psychedelic medicine. Under the hood, the company is applying precision to psychedelic medicine. This allows researchers and patients to explore new treatment options for brain health disorders. Backed by a $259 million equity financing in 4Q 2025.
Safety First
- Never pay for a job application.
- Do not share sensitive bank info.
- Verify the client before starting work.

